+26.1%
COHR vs MRNA
+909.7%
-883.6%
-60.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -13.0% | -6.5% | -6.4% | -13.0% |
| 7D | -28.4% | +8.4% | -36.8% | -28.4% |
| 30D | -49.8% | +28.8% | -78.6% | -49.7% |
| 3M | -48.3% | +329.2% | -377.5% | -48.7% |
| 6M | -49.4% | +416.9% | -466.4% | -53.9% |
| YTD | -8.0% | +718.8% | -726.8% | -31.3% |
| 1Y | +26.1% | +924.9% | -898.8% | -19.4% |
| All | +26.1% | +909.7% | -883.6% | -19.4% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling